GlassScriptPhysician profile
Amitav Rahman
NPI 1245907617
$5,037.98
in general payments reported to CMS, 2019-2025
37 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 84% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,007 · 2023: $1,494 · 2024: $1,273 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,999 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,999.06 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $959.92 | 2022-2025 | |
| Pfizer INC. | $792.99 | 2023-2025 | |
| Glaxosmithkline, LLC. | $466.94 | 2022-2025 | Arexvy, Bexsero, Shingrix |
| Lilly USA, LLC | $411.71 | 2022-2025 | Mounjaro, Zepbound |
| Amgen INC. | $359.84 | 2022-2025 | Otezla, Repatha, Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $358.31 | 2022 | |
| Novo Nordisk INC | $288.03 | 2022-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $116.48 | 2024-2025 | Airsupra |
| Exact Sciences Corporation | $110.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $96.50 | 2022-2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.49 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.97 | 2022-2025 | Xifaxan |
| Astellas Pharma US INC | $72.24 | 2024 | Veozah |
| Inspire Medical Systems, INC. | $60.74 | 2023-2024 | Inspire |
| Seqirus USA INC | $57.89 | 2024-2025 | Fluad, Flucelvax |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amitav Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.